Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Verve Therapeutics

VERV

VERV Verve Therapeutics NASDAQ
Add to watchlist
7.45
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    VERV Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 106.39k
    • Turnover 784.30k
    • P/E(TTM) --
    • Turnover % 0.19%
    • P/E(Static) --
    • Market Cap 468.85M
    • P/B 3.46
    • Shares 62.93M
    • 52 Week Range
      6.53
      17.02
    • Day Range
      7.15
      7.51

    About

    Verve Therapeutics, Inc. was incorporated on March 9, 2018 as a Delaware corporation. They are a genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course...
    • Highlight
      A clinical-stage biotech company pioneering gene editing therapies for cardiovascular diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/17/2021
    • Established Date
      03/09/2018
    • Full-time Employees
      255
    • Address
      201 Brookline Avenue Suite 601 Boston Massachusetts 02215
    • Tel
      1-617-6030070
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD